Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vanda Pharmaceuticals Inc. - Common Stock
(NQ:
VNDA
)
6.245
+0.125 (+2.04%)
Streaming Delayed Price
Updated: 10:48 AM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
345,196
Open
6.080
Bid (Size)
6.230 (400)
Ask (Size)
6.250 (600)
Prev. Close
6.120
Today's Range
6.030 - 6.280
52wk Range
3.809 - 9.600
Shares Outstanding
55,638,166
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Did Vanda Pharmaceuticals Stock Slide 7% Pre-Market Today?
↗
February 12, 2026
Via
Stocktwits
Vanda (VNDA) Q4 2025 Earnings Call Transcript
↗
February 11, 2026
Vanda (VNDA) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Performance
YTD
-24.3%
-24.3%
1 Month
-16.1%
-16.1%
3 Month
+43.9%
+43.9%
6 Month
+41.0%
+41.0%
1 Year
+31.5%
+31.5%
More News
Read More
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Stock Plummets 9.8% After Mixed Q4 2025 Earnings Report
↗
February 11, 2026
Via
Chartmill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
February 03, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
January 27, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Vanda Stock Drop 10% Premarket After FDA Rejects Jet Lag Drug Application
↗
January 08, 2026
Via
Stocktwits
VNDA Stock On Track To Open At Three-Year High – FDA Clears First New Motion Sickness Drug In Decades
↗
December 31, 2025
Via
Stocktwits
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
January 20, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
January 13, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Get insights into the top gainers and losers of Thursday's pre-market session.
↗
January 08, 2026
Via
Chartmill
Vanda’s FDA Moment: A High-Stakes Bet That Could Redefine The Stock
↗
December 29, 2025
Via
Stocktwits
The Christmas Party Is Still Ongoing In These Stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell
↗
December 26, 2025
Via
Stocktwits
Vanda Pharmaceuticals Says FDA Will Take More Time To Decide On Tradipitant Clinical Hold Re-Review
↗
November 28, 2025
Via
Stocktwits
In today's session, these stocks are experiencing unusual volume.
↗
January 02, 2026
Via
Chartmill
What's Going On With Vanda Pharmaceuticals Stock Wednesday?
↗
December 31, 2025
Via
Benzinga
Here are the top movers in Wednesday's session.
↗
December 31, 2025
Via
Chartmill
Top movers analysis in the middle of the day on 2025-12-31: top gainers and losers in today's session.
↗
December 31, 2025
Via
Chartmill
The market is filled with gapping stocks in Wednesday's session.
↗
December 31, 2025
Via
Chartmill
Get insights into the top gainers and losers of Wednesday's pre-market session.
↗
December 31, 2025
Via
Chartmill
Nasdaq, S&P 500 Futures Edge Lower For Final Session Of 2025: Why NVDA, TSLA, VNDA Are On Traders' Radar Today
↗
December 31, 2025
Via
Stocktwits
Topics
Artificial Intelligence
ETFs
Economy
Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
December 29, 2025
Via
MarketMinute
Topics
ETFs
Intellectual Property
This Smallcap Pharma Stock Is Gaining Retail Buzz Ahead Of A Key FDA Ruling
↗
December 26, 2025
Via
Stocktwits
Curious about the stocks that are showing activity after the closing bell on Thursday?
↗
December 04, 2025
Via
Chartmill
Should You Invest in This Under-the-Radar Weight Loss Stock?
↗
November 30, 2025
Via
The Motley Fool
Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat
↗
November 20, 2025
Via
Benzinga
Frequently Asked Questions
Is Vanda Pharmaceuticals Inc. - Common Stock publicly traded?
Yes, Vanda Pharmaceuticals Inc. - Common Stock is publicly traded.
What exchange does Vanda Pharmaceuticals Inc. - Common Stock trade on?
Vanda Pharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock?
The ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock is VNDA on the Nasdaq Stock Market
What is the current price of Vanda Pharmaceuticals Inc. - Common Stock?
The current price of Vanda Pharmaceuticals Inc. - Common Stock is 6.245
When was Vanda Pharmaceuticals Inc. - Common Stock last traded?
The last trade of Vanda Pharmaceuticals Inc. - Common Stock was at 02/13/26 10:48 AM ET
What is the market capitalization of Vanda Pharmaceuticals Inc. - Common Stock?
The market capitalization of Vanda Pharmaceuticals Inc. - Common Stock is 347.46M
How many shares of Vanda Pharmaceuticals Inc. - Common Stock are outstanding?
Vanda Pharmaceuticals Inc. - Common Stock has 347M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
